+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurodegenerative Disease Market Analysis 2019

  • ID: 4857821
  • Report
  • October 2019
  • Region: Global
  • 158 pages
  • Syngene Research
1 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical
  • MORE
The Global Neurodegenerative Disease market is poised to grow at a CAGR of 7.4% during the forecast period. The neurodegenerative disease is also known as neurodegeneration which is a condition in which there is a damage or wear and tear of the nerve cells. The patient suffering from a neurodegenerative disease does not have the ability to make decisions and which later results in the memory loss. The diseases that come under the category of the neurodegenerative diseases are Huntington disease, Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis.

Growing prevalence of neurological disorders, increasing public awareness, and strong product pipeline for neurodegenerative disease treatment are some of the factors driving the market growth. However, lack of awareness among the people in the under-developed regions and the absence of the developed curative treatment are hampering the growth of the market.

Based on the indication type, the Parkinson's disease segment is estimated to have a lucrative growth during the forecast period due to the disease is a slowly progressive neurologic disease that is characterized by a fixed inexpressive face, tremor at rest, slowing of voluntary movements, gait with short accelerating steps, peculiar posture and muscle weakness and low production of the neurotransmitter dopamine. The treatment involves the use of medication, such as levodopa and carbidopa.

The key vendors mentioned are AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, and UCB SA.

Drug Types Covered:
  • Selective Serotonin Reuptake Inhibitor
  • Dopamine Inhibitors
  • N-methyl-D-aspartate Receptor
  • Other Drug Types
Indication Types Covered:
  • Huntington Disease
  • Parkinson's Disease
  • Spinal Muscular Atrophy
  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Other Indication Types
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period.

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Neurodegenerative Disease Market, By Drug Type
5.1 Introduction
5.2 Selective Serotonin Reuptake Inhibitor
5.4 Dopamine Inhibitors
5.5 N-methyl-D-aspartate Receptor
5.6 Other Drug Types

6 Global Neurodegenerative Disease Market, By Indication Type
6.1 Introduction
6.2 Huntington Disease
6.3 Parkinson's Disease
6.4 Spinal Muscular Atrophy
6.5 Alzheimer's Disease
6.6 Amyotrophic Lateral Sclerosis
6.7 Other Indication Types

7 Global Neurodegenerative Disease Market, By Geography
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 South America
7.6 Middle East & Africa

8 Strategic Benchmarking

9 Vendors Landscape
9.1 AbbVie Inc.
9.2 Amneal Pharmaceuticals Inc.
9.3 Boehringer Ingelheim International GmbH
9.4 Hoffmann-La Roche Ltd
9.5 GlaxoSmithKline PLC
9.6 Merck & Co. Inc.
9.7 Pfizer Inc.
9.8 Teva Pharmaceutical
9.9 UCB SA

List of Data Tables
Table 1 Global Neurodegenerative Disease Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 3 Global Neurodegenerative Disease Market Outlook, By Selective Serotonin Reuptake Inhibitor (2016-2026) ($MN)
Table 4 Global Neurodegenerative Disease Market Outlook, By Dopamine Inhibitors (2016-2026) ($MN)
Table 5 Global Neurodegenerative Disease Market Outlook, By N-methyl-D-aspartate Receptor (2016-2026) ($MN)
Table 6 Global Neurodegenerative Disease Market Outlook, By Other Drug Types (2016-2026) ($MN)
Table 7 Global Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Table 8 Global Neurodegenerative Disease Market Outlook, By Huntington Disease (2016-2026) ($MN)
Table 9 Global Neurodegenerative Disease Market Outlook, By Parkinson's Disease (2016-2026) ($MN)
Table 10 Global Neurodegenerative Disease Market Outlook, By Spinal Muscular Atrophy (2016-2026) ($MN)
Table 11 Global Neurodegenerative Disease Market Outlook, By Alzheimer's Disease (2016-2026) ($MN)
Table 12 Global Neurodegenerative Disease Market Outlook, By Amyotrophic Lateral Sclerosis (2016-2026) ($MN)
Table 13 Global Neurodegenerative Disease Market Outlook, By Other Indication Types (2016-2026) ($MN)
Table 14 North America Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 15 North America Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Table 16 Europe Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 17 Europe Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Table 18 Asia Pacific Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 19 Asia Pacific Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Table 20 South America Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 21 South America Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Table 22 Middle East & Africa Neurodegenerative Disease Market Outlook, By Drug Type (2016-2026) ($MN)
Table 23 Middle East & Africa Neurodegenerative Disease Market Outlook, By Indication Type (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • Hoffmann-La Roche Ltd
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical
  • UCB SA
Note: Product cover images may vary from those shown
Adroll
adroll